[
  {
    "ts": null,
    "headline": "Thermo Fisher, Biogen, Gilead Sciences, Moderna, and QuidelOrtho Stocks Trade Up, What You Need To Know",
    "summary": "A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agreed to pause some tariffs for 90 days, signaling a potential turning point in ongoing tensions. This rollback cuts U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. imports to 10%, giving companies breathing room to reset inventories and supply chains.",
    "url": "https://finnhub.io/api/news?id=de61bb0fd808c39eb4637ed4d6bcb158d985380292e87942d3788c366eecff75",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747073469,
      "headline": "Thermo Fisher, Biogen, Gilead Sciences, Moderna, and QuidelOrtho Stocks Trade Up, What You Need To Know",
      "id": 134408968,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agreed to pause some tariffs for 90 days, signaling a potential turning point in ongoing tensions. This rollback cuts U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. imports to 10%, giving companies breathing room to reset inventories and supply chains.",
      "url": "https://finnhub.io/api/news?id=de61bb0fd808c39eb4637ed4d6bcb158d985380292e87942d3788c366eecff75"
    }
  },
  {
    "ts": null,
    "headline": "Trump executive order demands pharma industry price cuts",
    "summary": "U.S. President DonaldTrump signed a wide-reaching executive order on Monday directingdrugmakers to lower the prices of their medicines to align withwhat other countries pay that analysts and legal...",
    "url": "https://finnhub.io/api/news?id=95b7a1a761b01fdb72aaa640b00b5306de29c4352bb0b317801bb406ce0ea14e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747071937,
      "headline": "Trump executive order demands pharma industry price cuts",
      "id": 134391994,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "U.S. President DonaldTrump signed a wide-reaching executive order on Monday directingdrugmakers to lower the prices of their medicines to align withwhat other countries pay that analysts and legal...",
      "url": "https://finnhub.io/api/news?id=95b7a1a761b01fdb72aaa640b00b5306de29c4352bb0b317801bb406ce0ea14e"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
    "summary": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=15646069fd5599b7dce63f0920eac25a52a0cf9568c7d4930d1d68b336e1f18e",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747067760,
      "headline": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
      "id": 134404967,
      "image": "",
      "related": "GILD",
      "source": "MarketWatch",
      "summary": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=15646069fd5599b7dce63f0920eac25a52a0cf9568c7d4930d1d68b336e1f18e"
    }
  },
  {
    "ts": null,
    "headline": "Trump expected to sign order to slash US drug prices",
    "summary": "President Trump is expected to sign an executive order intended to cut US prescription drug prices in order to match drug prices overseas. Yahoo Finance senior health reporter Anjalee Khemlani outlines the many steps and government agencies involved in investigating and carrying out this act. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
    "url": "https://finnhub.io/api/news?id=2fac8407bab8089ee6638e31408578326a93679e005cdef8d76c714e3eae16d7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747061072,
      "headline": "Trump expected to sign order to slash US drug prices",
      "id": 134381623,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "President Trump is expected to sign an executive order intended to cut US prescription drug prices in order to match drug prices overseas. Yahoo Finance senior health reporter Anjalee Khemlani outlines the many steps and government agencies involved in investigating and carrying out this act. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
      "url": "https://finnhub.io/api/news?id=2fac8407bab8089ee6638e31408578326a93679e005cdef8d76c714e3eae16d7"
    }
  },
  {
    "ts": null,
    "headline": "The Zacks Analyst Blog Highlights Disney, Gilead Sciences, Eaton and Maui Land & Pineapple",
    "summary": "Disney, Gilead Sciences, Eaton and Maui Land & Pineapple are included in this Analyst Blog.",
    "url": "https://finnhub.io/api/news?id=80cdb666f570d0675eb29b1ef8e0fc43861b559232088819e47abdfc13de2403",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747059840,
      "headline": "The Zacks Analyst Blog Highlights Disney, Gilead Sciences, Eaton and Maui Land & Pineapple",
      "id": 134408819,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Disney, Gilead Sciences, Eaton and Maui Land & Pineapple are included in this Analyst Blog.",
      "url": "https://finnhub.io/api/news?id=80cdb666f570d0675eb29b1ef8e0fc43861b559232088819e47abdfc13de2403"
    }
  },
  {
    "ts": null,
    "headline": "US-China trade truce, April CPI, drug prices: 3 Things",
    "summary": "US stock futures (ES=F, NQ=F, YM=F) are surging Monday morning after US and China officials agreed to significant cuts to each country's respective tariff rates in a 90-day cool-off period. April's Consumer Price Index (CPI) is due out tomorrow, reporting month-over-month trends in US inflation rates. President Trump vows to cut prescription drug prices by as much as 80%. In turn, pharmaceutical stocks are seeing across the board pullbacks in pre-market trading. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
    "url": "https://finnhub.io/api/news?id=a938c055665a43b53f0a2cfa14795093ec3154f152ae163fa36fccfba6e48a3b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747055379,
      "headline": "US-China trade truce, April CPI, drug prices: 3 Things",
      "id": 134379227,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "US stock futures (ES=F, NQ=F, YM=F) are surging Monday morning after US and China officials agreed to significant cuts to each country's respective tariff rates in a 90-day cool-off period. April's Consumer Price Index (CPI) is due out tomorrow, reporting month-over-month trends in US inflation rates. President Trump vows to cut prescription drug prices by as much as 80%. In turn, pharmaceutical stocks are seeing across the board pullbacks in pre-market trading. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
      "url": "https://finnhub.io/api/news?id=a938c055665a43b53f0a2cfa14795093ec3154f152ae163fa36fccfba6e48a3b"
    }
  },
  {
    "ts": null,
    "headline": "Trump signs executive order to demand pharma industry cuts prices",
    "summary": "U.S. President DonaldTrump signed a wide-reaching executive order on Monday directingdrugmakers to lower the prices of their medicines to align withwhat other countries pay that analysts and legal...",
    "url": "https://finnhub.io/api/news?id=ec4041b18a83deee8d925724e089649cebf12a1ffdb68de0afc70ca58b59dc76",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747053873,
      "headline": "Trump signs executive order to demand pharma industry cuts prices",
      "id": 134385858,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "U.S. President DonaldTrump signed a wide-reaching executive order on Monday directingdrugmakers to lower the prices of their medicines to align withwhat other countries pay that analysts and legal...",
      "url": "https://finnhub.io/api/news?id=ec4041b18a83deee8d925724e089649cebf12a1ffdb68de0afc70ca58b59dc76"
    }
  },
  {
    "ts": null,
    "headline": "Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet",
    "summary": "Trump aims to cut US drug prices by 30-80% via Executive Order. Check out how pharma companies could be affected and how this may play out in the future.",
    "url": "https://finnhub.io/api/news?id=f3bdfb278b3d923fb7ecd9a0eb0a6ca51ad748153503c12329641a35d2d60c57",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747053003,
      "headline": "Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet",
      "id": 134386076,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1756275584/image_1756275584.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Trump aims to cut US drug prices by 30-80% via Executive Order. Check out how pharma companies could be affected and how this may play out in the future.",
      "url": "https://finnhub.io/api/news?id=f3bdfb278b3d923fb7ecd9a0eb0a6ca51ad748153503c12329641a35d2d60c57"
    }
  },
  {
    "ts": null,
    "headline": "Trump calls for broad drug price cuts in executive order, wants at least 59% drop",
    "summary": "U.S. President DonaldTrump signed a wide-reaching executive order on Monday directingdrugmakers to lower the prices of their medicines to align withwhat other countries pay that analysts and legal...",
    "url": "https://finnhub.io/api/news?id=db3a9fa4b0b4ac8f470145fe794d6bef7956541403b4ff2aa7c3e4ca1effb12c",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747049134,
      "headline": "Trump calls for broad drug price cuts in executive order, wants at least 59% drop",
      "id": 134382022,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "U.S. President DonaldTrump signed a wide-reaching executive order on Monday directingdrugmakers to lower the prices of their medicines to align withwhat other countries pay that analysts and legal...",
      "url": "https://finnhub.io/api/news?id=db3a9fa4b0b4ac8f470145fe794d6bef7956541403b4ff2aa7c3e4ca1effb12c"
    }
  },
  {
    "ts": null,
    "headline": "GILD Q1 Earnings Call: HIV Growth and Pipeline Momentum Offset Revenue Miss",
    "summary": "Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) missed Wall Street’s revenue expectations in Q1 CY2025, with sales flat year on year at $6.67 billion. The company’s full-year revenue guidance of $28.4 billion at the midpoint came in 1.1% below analysts’ estimates. Its non-GAAP profit of $1.81 per share was 2.1% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=eeadb3eb91b2f02bcaf08aadbbb3dc4cd52348d3ab1133a8f6c62aa725e4582d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747047744,
      "headline": "GILD Q1 Earnings Call: HIV Growth and Pipeline Momentum Offset Revenue Miss",
      "id": 134379463,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) missed Wall Street’s revenue expectations in Q1 CY2025, with sales flat year on year at $6.67 billion. The company’s full-year revenue guidance of $28.4 billion at the midpoint came in 1.1% below analysts’ estimates. Its non-GAAP profit of $1.81 per share was 2.1% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=eeadb3eb91b2f02bcaf08aadbbb3dc4cd52348d3ab1133a8f6c62aa725e4582d"
    }
  },
  {
    "ts": null,
    "headline": "Trump calls for broad drug price cuts in executive order",
    "summary": "U.S. President DonaldTrump plans to sign a wide-reaching executive order on Mondaydirecting drugmakers to lower the prices of their medicines toalign with what other countries pay. ...",
    "url": "https://finnhub.io/api/news?id=10d787c1f51178b366e02794b78dc7a2897e7d4d0ffcb16729de1a188ec8848d",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747045532,
      "headline": "Trump calls for broad drug price cuts in executive order",
      "id": 134380529,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "U.S. President DonaldTrump plans to sign a wide-reaching executive order on Mondaydirecting drugmakers to lower the prices of their medicines toalign with what other countries pay. ...",
      "url": "https://finnhub.io/api/news?id=10d787c1f51178b366e02794b78dc7a2897e7d4d0ffcb16729de1a188ec8848d"
    }
  }
]